Literature DB >> 6651240

Long-term effects of treatment on endocrine function in children with brain tumors.

P K Duffner, M E Cohen, S W Anderson, M L Voorhess, M H MacGillivray, A Panahon, M L Brecher.   

Abstract

Fourteen children with brain tumors received endocrine evaluations at least one year following completion of cranial irradiation. Treatment consisted of operation (13 patients), craniospinal irradiation (6), whole brain irradiation (5), posterior fossa irradiation (3), and chemotherapy (10). Endocrine evaluation included bone age roentgenography and measurement of growth hormone (using sequential arginine and insulin stimulation), thyroxine, thyroid-stimulating hormone, plasma cortisol, testosterone, prolactin, and urinary follicle-stimulating hormone and luteinizing hormone. Ten of 12 children (83%) had abnormal responses to both tests of growth hormone stimulation. All growth hormone-deficient patients treated prior to puberty and tested at least 2 years following completion of cranial irradiation had decelerated linear growth. Results of thyroid function tests were abnormal in 4 patients: 2 patients had evidence of primary hypothyroidism, and 2 showed secondary or tertiary hypothyroidism. Two patients had inadequate cortisol responses to insulin hypoglycemia. Urinary follicle-stimulating hormone and luteinizing hormone, serum prolactin, and serum testosterone levels were appropriate for age in all patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651240     DOI: 10.1002/ana.410140506

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

1.  Population Pharmacokinetics of Oral Topotecan in Infants and Very Young Children with Brain Tumors Demonstrates a Role of ABCG2 rs4148157 on the Absorption Rate Constant.

Authors:  Jessica K Roberts; Anna V Birg; Tong Lin; Vinay M Daryani; John C Panetta; Alberto Broniscer; Giles W Robinson; Amar J Gajjar; Clinton F Stewart
Journal:  Drug Metab Dispos       Date:  2016-04-06       Impact factor: 3.922

2.  The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation.

Authors:  Christine Lauro; Margaret E Macy; Philip Zeitler; Jennifer Backus; Pamela Mettler; Nicholas Foreman; Arthur K Liu
Journal:  J Pediatr Endocrinol Metab       Date:  2014-03       Impact factor: 1.634

3.  Pilot study on sex hormone levels and fertility in women with malignant gliomas.

Authors:  Matthias Preusser; Stefanie Seywald; Katarzyna Elandt; Christine Kurz; Andrea Rottenfusser; Karin Dieckmann; Gabriele Altorjai; Christoph C Zielinski; Christine Marosi
Journal:  J Neurooncol       Date:  2011-11-20       Impact factor: 4.130

Review 4.  A review of clinical and histological features of Spanish paediatric medulloblastomas during the last 21 years.

Authors:  Alejandro Urberuaga; Aurora Navajas; Juan Burgos; José Ignacio Pijoán
Journal:  Childs Nerv Syst       Date:  2005-11-09       Impact factor: 1.475

5.  Multidisciplinary Management of Medulloblastoma: Consensus, Challenges, and Controversies.

Authors:  Abhishek Chatterjee; Madan Maitre; Archya Dasgupta; Epari Sridhar; Tejpal Gupta
Journal:  Methods Mol Biol       Date:  2022

6.  Hemispheric cerebral tumors in children. Long-term prognosis concerning survival rate and quality of life--considerations on a series of 64 cases operated upon.

Authors:  M R Balestrini; M Zanette; R Micheli; M Fornari; C L Solero; G Broggi
Journal:  Childs Nerv Syst       Date:  1990-05       Impact factor: 1.475

7.  Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours.

Authors:  E A Livesey; C G Brook
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

8.  Growth response to growth hormone therapy following craniospinal irradiation.

Authors:  P E Clayton; S M Shalet; D A Price
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

Review 9.  An integrated approach to the treatment of chiasmatic-hypothalamic gliomas.

Authors:  M Garvey; R J Packer
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

10.  Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours.

Authors:  John C Panetta; Jessica K Roberts; Jie Huang; Tong Lin; Vinay M Daryani; K Elaine Harstead; Yogesh T Patel; Arzu Onar-Thomas; Olivia Campagne; Deborah A Ward; Alberto Broniscer; Giles Robinson; Amar Gajjar; Clinton F Stewart
Journal:  Br J Clin Pharmacol       Date:  2020-01-08       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.